See the latest news and media coverage for PolarisQB. We track all announcements, press releases, and industry mentions in real time, all in one place.
Quantum-aided drug discovery platform
polarisqb.comLast updated
In short: PolarisQB advanced quantum machine learning for drug design, receiving DARPA awards and demonstrating QuADD's superiority over AI in drug discovery.
The study shows significant improvements in ADMET benchmarks, enabling earlier elimination of toxic compounds. Results highlight gains in CYP3A4 and hERG predictions.
They collaborate with Cleveland Clinic researchers using IBM Quantum System One to advance quantum machine learning for ADME-Tox prediction in drug discovery.
The paper by its Director of Chemistry and CEO compares QuADD platform favorably to BInD in small-molecule generation for drug design.
These features improve AI models on 8/10 ADMET benchmarks and integrate into QuADD for accurate scoring.
DURHAM, N.C., Aug. 13, 2025 — Polaris Quantum Biotech (PolarisQB), a leader in quantum-powered life science solutions, has announced the official launch of...
DURHAM, NC, UNITED STATES, September 30, 2025 /EINPresswire.com/ -- The Defense Advanced Research Projects Agency (DARPA) awarded PolarisQB an Embedded ...
Bill Shipman, co-founder and chief technology officer of Polaris Quantum Biotech, a North Carolina-based company that uses quantum computing to help discover...
Track PolarisQB and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to PolarisQB and other trending companies.